JP2005519073A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519073A5
JP2005519073A5 JP2003567333A JP2003567333A JP2005519073A5 JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5 JP 2003567333 A JP2003567333 A JP 2003567333A JP 2003567333 A JP2003567333 A JP 2003567333A JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5
Authority
JP
Japan
Prior art keywords
compound according
compound
group
metabolite
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003567333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001845 external-priority patent/WO2003068148A2/en
Publication of JP2005519073A publication Critical patent/JP2005519073A/ja
Publication of JP2005519073A5 publication Critical patent/JP2005519073A5/ja
Withdrawn legal-status Critical Current

Links

JP2003567333A 2002-01-18 2003-01-21 睡眠標的モジュレーターを使用する睡眠障害の治療 Withdrawn JP2005519073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34991202P 2002-01-18 2002-01-18
US35732002P 2002-02-15 2002-02-15
PCT/US2003/001845 WO2003068148A2 (en) 2002-01-18 2003-01-21 Treatment of sleep disorders using sleep target modulators

Publications (2)

Publication Number Publication Date
JP2005519073A JP2005519073A (ja) 2005-06-30
JP2005519073A5 true JP2005519073A5 (enExample) 2005-12-22

Family

ID=27737408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003567333A Withdrawn JP2005519073A (ja) 2002-01-18 2003-01-21 睡眠標的モジュレーターを使用する睡眠障害の治療

Country Status (6)

Country Link
US (2) US20060009465A1 (enExample)
EP (1) EP1471913A2 (enExample)
JP (1) JP2005519073A (enExample)
AU (1) AU2003210598A1 (enExample)
CA (1) CA2473586A1 (enExample)
WO (1) WO2003068148A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY28538A1 (es) * 2003-09-26 2005-04-29 Vertex Pharma Derivados de fenil-piperazina como moduladores de receptores muscarínicos
WO2005107700A2 (en) * 2004-04-26 2005-11-17 Immuneregen Biosciences, Inc. Anti-aging effects of substance p
JP4613031B2 (ja) * 2004-05-06 2011-01-12 エスエス製薬株式会社 催眠剤組成物
DK1931346T3 (da) * 2005-09-09 2012-10-22 Angelini Labopharm Llc Trazodonsammensætning til indgivelse en gang om dagen
CN101242856A (zh) * 2005-09-09 2008-08-13 莱博法姆公司 持续药物释放的组合物
WO2007098202A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid based apparatus, system, and method for therapeutic treatment of a patient
WO2008070795A2 (en) * 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
JP2011500143A (ja) 2007-10-09 2011-01-06 イムセラ・メディカル・インコーポレーテッド 選択的刺激のための装置、システム、及び方法
CA2738479C (en) 2008-10-09 2017-11-28 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
PT2314182E (pt) 2009-10-23 2011-10-17 Gruppo Cimbali Spa Máquina de café com regulação de pressão de distribuição e um método correspondente
AU2010318651A1 (en) 2009-11-10 2012-05-03 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
ES2673286T3 (es) 2011-02-11 2018-06-21 Zx Pharma, Llc Formulaciones multiparticuladas de L-mentol y métodos relacionados
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US20120315337A1 (en) * 2011-06-07 2012-12-13 Shah Syed Multiparticulate 5-htp compositions and related methods
US9266881B2 (en) 2011-11-14 2016-02-23 Merck Sharp & Dohme Corp. Triazolopyridinone PDE10 inhibitors
SMT201900021T1 (it) 2013-04-23 2019-02-28 Zx Pharma Llc Composizione gastroresistente a base di multiparticolato con sottorivestimento proteinaceo
CN107635549A (zh) 2015-03-26 2018-01-26 杰奎琳·M·艾弗森 抑制与宿醉相关的症状的方法和组合物
WO2019192903A1 (de) * 2018-04-06 2019-10-10 Basf Se Verfahren zur herstellung von aminen
JP2025539064A (ja) * 2022-11-11 2025-12-03 ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド トラゾドンを使用して5-ht2a受容体アゴニストの効果を逆転させる方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders

Similar Documents

Publication Publication Date Title
JP2005519073A5 (enExample)
JP2024050527A5 (enExample)
JP2010523476A5 (enExample)
JP2011515482A5 (enExample)
JP2014051526A5 (enExample)
JP2009143956A5 (enExample)
JP2018135343A5 (enExample)
JP2011519854A5 (enExample)
JP2014507455A5 (enExample)
JP2014508811A5 (enExample)
JP2009531277A5 (enExample)
JP2007508361A5 (enExample)
ME02766B (me) Derivati arilmetoksi izoindolina i kompozicije koje ih obuhvataju i postupci njihove primene
JP2010503688A5 (enExample)
JP2005508349A5 (enExample)
JP2004525117A5 (enExample)
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
JP2007523155A5 (enExample)
JP2013537203A5 (enExample)
JP2014506907A5 (enExample)
JP2007508360A5 (enExample)
JP2019519587A5 (enExample)
JP2015517555A5 (enExample)
JP2005539045A5 (enExample)
JP2007534702A5 (enExample)